glp-1 kidney disease news Design and discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis What Ozempic and other GLP-1

Have kidney or liver conditions

Nucleic acid therapeutics: a focus on the development of aptamers

The future of oral GLP-1 medications The oral semaglutide drops space is evolving rapidly

The removal of N-nitrosodimethylamine (NDMA) and other disinfection byproducts (DBPs), such as trihalomethanes (THMs) and haloacetic acids (HAAs), is essential for compliance with regulations like the California Surface Water Treatment Rule

Clinical studies have also suggested a significant role of growth hormone in immune regulation, and the growth hormone receptor is expressed on different subpopulations of lymphocytes (14)

(2024, January 10)